Opsens focuses mainly on physiological measurements in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 80,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.

Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.



Contact Information
Opsens Inc.
[email protected]

Latest

Mar 04, 2019, 07:00 ET Opsens Appoints Alan Milinazzo as Executive Chairman of the Board of Directors

QUEBEC CITY, March 4, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX: OPS) (OTCQX: OPSSF) is pleased to announce the appointment of Mr. Alan Milinazzo as Executive Chairman of the Board of Directors....

Feb 27, 2019, 15:54 ET Opsens announces credit agreement with CIBC Innovation Banking

QUEBEC CITY, Feb. 27, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX: OPS) (OTCQX: OPSSF) is pleased to announce that it has entered into an $8 M credit agreement (the "Agreement") with CIBC...

Jan 24, 2019, 16:12 ET Opsens - Election results for the Board of directors

QUEBEC CITY, Jan. 24, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today held its annual general shareholders' meeting (the "Meeting") in Quebec City, Canada. ...

Jan 14, 2019, 07:00 ET Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase

QUEBEC CITY, Jan. 14, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today reported its results for the first quarter of 2019. Highlights Consolidated revenues...

Jan 09, 2019, 07:00 ET Opsens' dPR obtains CE marking to sell in Europe

QUEBEC CITY, Jan. 9, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) has been granted CE marking for its diastolic pressure algorithm ("dPR"). Opsens' dPR...

Nov 28, 2018, 07:00 ET UPDATE - Opsens reports Q4 and FY2018 results

Please note that a word was missing in the subtitle. The updated subtitle follows: RECORD ANNUAL REVENUE SURPASS $24 M AND RECORD QUARTERLY FFR REVENUES AT $4.1 M QUEBEC CITY, Nov. 28, 2018 /CNW...

Nov 27, 2018, 07:00 ET Opsens receives Health Canada approval for dPR intended for the diagnosis of coronary stenosis with the heart at rest

QUEBEC CITY, Nov. 27, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX: OPS) (OTCQX: OPSSF) announced today that it has obtained approval from Health Canada to market its dPR Proprietary Resting...

Nov 08, 2018, 07:00 ET Opsens - First use of dPR for the diagnosis of coronary stenosis with the heart at rest

QUEBEC CITY, Nov. 8, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX: OPS) (OTCQX: OPSSF) announces that its Diastolic Pressure Ratio called dPR, has been used for the first time by Dr. Hitoshi...

Nov 01, 2018, 08:00 ET Opsens - 50,000 patients diagnosed with the OptoWire

QUEBEC CITY, Nov. 1, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) has reached an important milestone with more than 50,000 patients assessed with the...

Oct 03, 2018, 08:00 ET Opsens to Host Investor Webinar on Thursday, October 4 to Provide Update on Recent Developments

QUEBEC CITY, Oct. 3, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) will host an investor webinar and live Q&A session on Thursday, October 4, 2018, at 4.05 p.m....

Sep 20, 2018, 08:00 ET Opsens - New product for the diagnosis of coronary stenosis with the heart at rest

QUEBEC CITY, Sept. 20, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) announces it has developed a product that will allow the diagnosis of coronary heart...

Jul 12, 2018, 07:00 ET Opsens Reports Q3 2018 Results - Quarterly Revenues Eclipse $6.4 M

QUEBEC CITY, July 12, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today reported its results for the third quarter ended May 31, 2018. HIGHLIGHTS FOR THE...

Apr 24, 2018, 07:00 ET Opsens applauds Japanese government new regulation supporting diagnosis, such as FFR, before treatment of coronary stenosis

QUEBEC CITY, April 24, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) applauds Japan's Ministry of Health, Labor and Welfare ("MHLW") on its new regulation...

Apr 12, 2018, 07:00 ET Opsens reports Q2 2018 results - Consolidated product sales up 44%

QUEBEC CITY, April 12, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today reported its results for the second quarter ended February 28, 2018. Highlights...

Apr 03, 2018, 09:22 ET Opsens' technology granted FDA approval in Abiomed's Impella Cardiac Pump®

QUEBEC CITY, April 3, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) announces that the integration of Opsens' technology, within the Impella Cardiac Pump®...

Jan 31, 2018, 10:05 ET Opsens Reports Results of Shareholders Vote

QUEBEC CITY, Jan. 31, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX: OPS) (OTCQX: OPSSF) held its Shareholders' Annual Meeting ("the Meeting") on January 23, 2018. At the Meeting, all nominated...

Jan 23, 2018, 10:53 ET Opsens Announces Election Results for the Board of Directors and the Retirement of Claude Belleville

QUEBEC CITY, Jan. 23, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today held its annual general shareholders' meeting (the "Meeting") at its head office in...

Jan 15, 2018, 07:00 ET Opsens Reports Q1 2018 Results - Record Quarterly Revenues With Growth in all Geographic Regions

QUEBEC CITY, Jan. 15, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today reported its results for the first quarter ended November 30, 2017. Highlights...

Nov 27, 2017, 07:00 ET Opsens' Japanese partner Zeon medical proceeds with Conversion of US$2 million Debenture

QUEBEC CITY, Nov. 27, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) is pleased to announce the conversion of the US$2 million debenture held by Zeon Medical...

Nov 15, 2017, 07:00 ET Opsens Reports 2017 Results - Consolidated Revenues Up 85% for Fiscal 2017

QUEBEC CITY, Nov. 15, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today reported its results for the year ended August 31, 2017. Highlights Record...

Oct 24, 2017, 08:00 ET Opsens Gets Technological Award

QUEBEC CITY, Oct. 24, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens"or the "Company") (TSX: OPS) (OTCQX: OPSSF) is proud to announce that its wholly owned subsidiary Opsens Solutions has received the...

Sep 13, 2017, 07:00 ET Opsens Presents a Short Film at the International Medical Film Festival - Quebec in Good Health

QUEBEC CITY, Sept. 13, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) is proud to announce that it has been invited to present a short film as part of...

Jun 29, 2017, 06:30 ET Opsens Reports Q3 2017 Results - Another Record Quarter with Revenues Up 130% to $4.9 Million

QUEBEC CITY, June 29, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today reported its results for the third quarter ended May 31, 2017. HIGHLIGHTS Growth in...

Jun 07, 2017, 07:00 ET Opsens - Robin Villeneuve Appointed as Chief Financial Officer

QUEBEC CITY, June 7, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today announces that to support its growth phase and positioning in the medical market, the...

May 16, 2017, 08:30 ET Opsens Inc. Presentation Now Available for On-Demand Viewing

Opsens Inc. (OTCQX: OPSSF), based in Quebec, focused on the measure of Fractional Flow Reserve ("FFR") in interventional cardiology, today announced that the May 11 presentation from Louis Laflamme,...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE